Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2021 | The contribution of vascular disease to cognitive impairment and Alzheimer’s pathology

Atticus Hainsworth • 4 Aug 2021
AAIC 2021
Alzheimer’s Disease Dementia

Atticus Hainsworth, PhD, St. George’s University of London, discusses the role of vascular diseases in contributing to cognitive impairment and Alzheimer’s disease (AD) pathology. He describes some of the conditions which may cause cognitive impairment or worsen pathology seen in AD patients and suggests that vascular diseases may be a viable target for dementia treatments. This interview took place during the Alzheimer’s Association International Conference (AAIC), 2021.

Disclosures

Atticus H Hainsworth has received honoraria from Eli-Lilly and from NIA, he chairs the Vascular Cognitive Disorders professional interest area within ISTAART and he leads the MRC-Dementias Platform UK (DPUK) Vascular Experimental Medicine group.

More from Atticus Hainsworth

Next steps in VCID research: molecular targets and fluid biomarkers
3:32
Next steps in VCID research: molecular targets and fluid biomarkers
Atticus Hainsworth • 16 Aug 2022
Lowering blood pressure as a treatment for VCID
5:36
Lowering blood pressure as a treatment for VCID
Atticus Hainsworth • 16 Aug 2022
Arterial spin labelling for cerebral blood flow
2:00
Arterial spin labelling for cerebral blood flow
Atticus Hainsworth • 16 Aug 2022
PASTIS: investigating the impact of tadalafil on cerebral blood flow in small vessel disease
5:03
PASTIS: investigating the impact of tadalafil on cerebral blood flow in small vessel disease
Atticus Hainsworth • 16 Aug 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals